Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevalence of overweight and metabolic syndrome, and associated sociodemographic factors among adult Ecuadorian populations: the ENSANUT-ECU study.

Journal of endocrinological investigation·2020

Same author

Genetic and environmental influences on circulating NK and T cells and their relation to bipolar disorder.

International journal of bipolar disorders·2019

Same author

[The dysregulated brain - Consequences of spatial and temporal brain complexity for bipolar disorder pathophysiology and diagnosis].

Tijdschrift voor psychiatrie·2018

Same author

Th17/T regulator cell balance and NK cell numbers in relation to psychosis liability and social stress reactivity.

Brain, behavior, and immunity·2018

Same author

Immune dysregulation in offspring of a bipolar parent. Altered serum levels of immune growth factors at adolescent age.

Brain, behavior, and immunity·2017

Same author

The seroprevalence of antithyroid peroxidase antibodies in bipolar families and bipolar twins: results from two longitudinal studies.

International journal of bipolar disorders·2017

Search research articles

Related Experiment Video

Updated: Jun 25, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

Published on: June 27, 2011

Reversible thyroid dysfunction during treatment with GM-CSF.

K Hoekman¹, B M von Blomberg-van der Flier, J Wagstaff

¹Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

Lancet (London, England)

|August 31, 1991

Summary

Granulocyte-macrophage colony-stimulating factor (GM-CSF) may trigger thyroid dysfunction in patients with pre-existing thyroid antibodies. This effect was temporary, resolving after GM-CSF treatment cessation.

More Related Videos

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Published on: December 21, 2013

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Related Experiment Videos

Last Updated: Jun 25, 2026

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

A Cell Free Assay System Estimating the Neutralizing Capacity of GM-CSF Antibody using Recombinant Soluble GM-CSF Receptor

Published on: June 27, 2011

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Implanting Glass Spinal Cord Windows in Adult Mice with Experimental Autoimmune Encephalomyelitis

Published on: December 21, 2013

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

Area of Science:

Oncology
Immunology
Endocrinology

Background:

Autoimmunity against thyroid antigens can complicate cancer treatment.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is used in cancer therapy.
The impact of GM-CSF on thyroid autoimmunity requires investigation.

Purpose of the Study:

To determine if GM-CSF induces or exacerbates thyroid autoimmunity.
To assess thyroid function and autoantibody status during GM-CSF therapy.

Main Methods:

Studied 14 advanced breast cancer and 11 soft-tissue sarcoma patients.
Administered doxorubicin, cyclophosphamide, and GM-CSF intravenously.
Monitored thyroid function and autoantibodies before and during treatment.

Main Results:

Two patients with pre-existing thyroid antibodies developed transient thyroid dysfunction.
Thyroid dysfunction resolved after GM-CSF cessation.
No new autoimmune abnormalities were observed.

Conclusions:

GM-CSF may transiently exacerbate thyroid autoimmunity in susceptible individuals.
Antigen-presenting cell stimulation by GM-CSF could explain this phenomenon.
Further research is needed to understand GM-CSF's immunomodulatory effects.